Alberto Gil Jimenez

Biomarker analysis and updated clinical follow-up of preoperative ipilimumab (ipi) plus nivolumab (nivo) in stage III urothelial cancer (NABUCCO).

A. Broeks, T. Schumacher, L. Wessels, 2020 .